Cello Health Share Price (CLL)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Cello Health Plc	LSE:CLL	London	Ordinary Share	GB00B0310763	ORD 10P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	127.50	5,203	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
126.00		129.00	127.50	127.50	127.50

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Media	165.57	8.42	6.27	20.3	135

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
14:15:01	O	41	126.255	GBX

Related Shares
Relx (REL), Informa (INF), Mediazest (MDZ), Catenae Innovation (CTEA)

Cello Health (CLL) Latest News

Cello Health News

Date	Time	Source	Headline
10/17/2019	12:00	IHNW	FeaturedADVFN Creates Dedicated Platform as Interest Surges for Trusts and Fund
10/09/2019	5:16	IHNW	Featured20\|30 Group appoints Tim Pearce as Commercial Director
07/10/2019	15:23	ALNC	Cello Health Secures 11% Holding In Access Intelligence
07/10/2019	13:39	UKREG	Access Intelligence PLC Holding(s) in Company
07/10/2019	13:00	UKREG	Cello Health PLC Total Voting Rights
02/10/2019	10:23	ALNC	Cello Health Sells Social Media Analytics Unit To Access Intelligence
02/10/2019	08:45	ALNCF	Alliance News Flash Headline
02/10/2019	08:40	UKREG	Cello Health PLC Disposal
18/9/2019	11:09	ALNC	Cello Health Interim Profit Rises Sharply On Unit Performance
18/9/2019	07:00	UKREG	Cello Health PLC Interim Results
23/8/2019	10:40	UKREG	Cello Health PLC Holding(s) in Company
16/8/2019	10:45	ALNC	Cello Health Acquires Innovative Science Solutions For USD11 Million

More Cello Health News

Cello Health Takeover Rumours

Cello Health (CLL) Share Charts

1 Year Cello Health Chart

1 Month Cello Health Chart

Intraday Cello Health Chart

Cello Health (CLL) Discussions and Chat

Cello Health Forums and Chat

Date	Time	Title	Posts
02/10/2019	11:12	Cello - solid prospects	1,041
29/1/2015	16:56	CELLO GROUP?	9
12/1/2005	16:17	Cello or EQI?	-

Add a New Thread

Cello Health (CLL) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2019-10-18 13:15:02	126.26	41	51.76	O
2019-10-18 09:11:04	126.80	5,162	6,545.42	O

View all Cello Health trades in real-time

Cello Health (CLL) Top Chat Posts

Date	Subject
18/10/2019 09:20	Cello Health Daily Update: Cello Health Plc is listed in the Media sector of the London Stock Exchange with ticker CLL. The last closing price for Cello Health was 127.50p. Cello Health Plc has a 4 week average price of 123p and a 12 week average price of 119p. The 1 year high share price is 138.50p while the 1 year low share price is currently 95.70p. There are currently 106,088,917 shares in issue and the average daily traded volume is 26,328 shares. The market capitalisation of Cello Health Plc is £135,263,369.18. Read Full Thread Reply
21/3/2019 10:44	davebowler: Cenkos; Organic momentum continues Today’s largely in-line results were well flagged by January’s trading update, but there are notable beats on EPS, DPS and Net cash. The group continues its organically focused delivery, leveraging Signal’s digital capabilities into the healthcare space, alongside new office openings. This will continue Cello’s migration over time into a more healthcare-focused, US-centric and higher margin business. We feel the defensive nature and FCF potential of Cello are not fairly valued in the current share price. Read Full Thread Follow Reply
08/2/2017 09:52	qs99: Continued good moves....a great story really IMO given fund raise, more than required, implying more deals (+use of debt) in future, tech focus in new broker notes, share price already 10%+ above placing price as well received....more to come IMO as reckon from this share price rise, there are a few who are buying into story....DYOR and gla Read Full Thread Follow Reply
06/2/2017 12:06	davebowler: FinnCap; Post the placing, Cello has net cash and, with an acquisition, has signalled its intent to invest for growth now that the VAT issue is firmly behind it. We continue to believe Pulsar, its social media tool, is in the share price for free, but also increasingly that Cello has developed a widening range of technologies that are performing well and support good profit growth potential. Cello is moving away from an ‘hours utilised and billed' type model towards a technology-backed model, a more valuable proposition. Read Full Thread Follow Reply
01/2/2017 11:39	zipstuck: The oversubscribed placing underpins the share price and there is all to play for in 2017 Read Full Thread Follow Reply
19/1/2017 09:36	davebowler: Price: 100.0p Target Price: 132.0p finncap.com Cello has confirmed the Group delivered an encouraging trading performance in 2016 and 2017 begins with good momentum from existing and new clients. Most importantly for our buy case, there has been an ‘excellent performance’ from Cello’s growing suite of software-enabled products. We make no changes to our forecasts and continue to believe the share price significantly undervalues the technologies Cello has developed, most notably Pulsar its social media analytics tool which we believe is in the price for free. Read Full Thread Follow Reply
28/9/2016 09:58	davebowler: Finncap; Price: 106.0p Target Price: 132p Cello has an overlooked and potentially significantly undervalued asset that is now out of development phase. Cello Pulsar is a social media analytics tool that has significant points of difference to the competition. In the right hands, social media data can inform, direct and optimise marketing campaigns but to date its usage has been constrained by early-stage science and customer unfamiliarity. Competitors in this area have individually raised nearly half of Cello's market cap, emphasising Pulsar’s potential to add very material value to the share price. We initiate at Buy. Read Full Thread Follow Reply
03/6/2014 17:44	qs9: nice IMO to see directors taking advantage of recent share price weakness... Read Full Thread Follow Reply
08/5/2013 14:58	hpcg: I think its a bit chicken and egg with regards to liquidity / spread; its thinly traded which puts people off. If they participated then there would be more liquidity! However I'm speculating as to the motives of others, and it could just be that investors want to see more prolonged evidence of progress. If the company does the business the share price will as well. Read Full Thread Follow Reply
01/7/2010 22:20	glasshalfull: Signs of life in the CLL share price in the last few sessions. If recent years are anything to go by then there is a very strong chance of a trading update anytime now. Trading statements released on the following dates:- 3rd July 2009 4th July 2008 12th July 2007 3rd July 2006 2010 market updates 19th January 2010 - pre-close trading update indicated that there were signs of improvement in markets. 16th March 2010 preliminary results confirmed improvement, "Cello has strong revenue pipelines in Research and Consulting and Tangible has also seen a marked increase in levels of new business activity." 17th May 2010 - AGM statement noted "The Group has therefore performed strongly during the first quarter of 2010. While there remains economic uncertainty, we are growing in confidence about the Group's performance." So, given that guidance in 2010 has been of improving markets and strong performance (so far) I'm hopeful that CLL will be in line with market forecasts at the very least....and there's always a possibility that they may be ahead. Worth reiterating m my earlier post - 364 Altium snippet on AGM update "...we continue to view the group's stock as substantially undervalued and would cite: (a) the quality of its underlying operating assets, (b) robust financials (debt well within long-term facilities of £17m), and (c) earnings growth potential as a recovery in research and marketing spend plays through a scaleable cost base, as key attractions. We are nudging up our target price from 46p to 49p (an undemanding 7x FY 2010E PER / c.48% upside) to reflect the encouraging momentum highlighted above and reiterate our BUY recommendation." Regards, GHF Read Full Thread Follow Reply
01/4/2010 12:40	glasshalfull: Well I disagree GCI :-) I've been nibbling away and have bought a few CLL since results which I expect to represent the nadir of the share price underperformance. I had researched and was a holder of CLL back in 2006 and discovered that I still had a few (dormant account), so only recently got up to speed on developments since. My interest was rekindled having carried out comprehensive research on Adventis (ATG) a marketing services company - see link below - and I noticed that both ATG and CLL had failed to enjoy the shareprice recovery that many of their peers had. http://boards.fool.co.uk/Message.asp?mid=11859117 I've started a write-up on CLL and will post when complete. Regards GHF Read Full Thread Follow Reply

Cello Health share price data is direct from the London Stock Exchange

Your Recent History

LSE

CLL

Cello Heal..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20191019 04:38:25